Identify improvement levers
Surface cost and margin improvement opportunities that can inform your valuation.
On-site, PAN India: understand the true cost of making each product, and where efficiency and margins can improve.
Strong revenues can hide inefficient manufacturing. Idle capacity, slow changeovers, manual processes and costly raw material sourcing all reduce margins. These factors directly affect what a manufacturing business is worth and how quickly an investment pays back.
Suchigo Consulting provides operational due diligence for pharmaceutical and medical device manufacturing facilities, for acquirers, investors and manufacturers from India and overseas. We assess how efficiently the plant converts capacity, materials and people into saleable products, and separate high-performing product lines from those that draw down margins.
We review operations, materials and pricing to show where capacity is being used, where costs build up and what the findings mean for the business.
| Area | What we review | What it tells you |
|---|---|---|
| Capacity utilisation | Installed versus actual capacity, Overall Equipment Effectiveness (OEE), downtime patterns, changeover times and bottlenecks | How much more the facility can produce without new capital investment |
| Process automation | Manual versus automated operations across assembly, welding, inspection and packaging, and the likely return on automation | Where automation can lower costs, improve consistency and reduce manpower dependence |
| Strategic raw material sourcing | Bill of Materials (BOM) costs, key suppliers, single-source dependencies, purchase prices and alternative sources | Whether material costs and supply risks are under control |
| Competitor pricing analysis | Unit production cost (materials, conversion and overheads) compared with market price bands in domestic and export markets | Whether products are priced competitively and where margins can improve |
Buyers often value a manufacturing business on its current earnings. An operational due diligence shows whether those earnings are sustainable and where there is real upside. Our assessment helps you:
Surface cost and margin improvement opportunities that can inform your valuation.
Flag product lines that may not be commercially viable at their current cost and price.
Build a realistic view of post-acquisition capital expenditure and operational priorities.
Our experts work with your team to understand the facility, review the evidence and turn findings into priorities.
We agree the products in scope and review production, cost, purchasing and sales data.
We visit the facility, PAN India, and observe operations, equipment use and material flow first-hand.
Our senior experts assess capacity, automation potential, sourcing and pricing against industry practice and competitors.
Your management receives a clear report on current efficiency, cost-saving opportunities and indicative priorities. After the report, Suchigo can advise on implementing improvements for the complete plan or selected areas, working alongside your team as catalyst and advisor.
Led by Mr. Sunil Gokhale, with over 43 years of CEO-level experience, our senior experts have managed plant operations, product costing and vendor negotiations in pharmaceutical and medical device manufacturing.
We know where costs build up on the shop floor and in the supply chain, and can distinguish real efficiency gains from theoretical ones.
We draw on a wide network of industry specialists, work alongside your team as catalyst and advisor, and carry out all assessments under strict confidentiality.
Share your requirement and speak with Suchigo Consulting about operational due diligence for your facility or investment.
Share Your Requirement